Rare cases of COVID returning pose questions for Pfizer pill
May 10, 2022 at 09:42 AM EDT
Pfizer's new OVID-19 pill has now come under scrutiny as a small number of patients relapsed after taking the drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|